Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
755.97
-8.96 (-1.17%)
Mar 6, 2026, 10:47 AM EST - Market open
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$815.04
Upside
+7.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $745 → $765 | Hold | Maintains | $745 → $765 | +1.19% | Mar 2, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $865 → $975 | Strong Buy | Maintains | $865 → $975 | +28.97% | Feb 9, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $850 → $950 | Buy | Maintains | $850 → $950 | +25.67% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $750 → $865 | Buy | Reiterates | $750 → $865 | +14.42% | Feb 2, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $768 → $769 | Hold | Maintains | $768 → $769 | +1.72% | Feb 2, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $745 → $800 | Hold | Maintains | $745 → $800 | +5.82% | Feb 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $740 → $800 | Buy | Maintains | $740 → $800 | +5.82% | Feb 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $820 → $818 | Strong Buy | Maintains | $820 → $818 | +8.21% | Feb 2, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $750 → $875 | Buy | Maintains | $750 → $875 | +15.75% | Jan 22, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $798 → $820 | Strong Buy | Maintains | $798 → $820 | +8.47% | Jan 8, 2026 |
| B of A Securities | B of A Securities | Sell → Strong Buy Upgrades $627 → $860 | Sell → Strong Buy | Upgrades | $627 → $860 | +13.76% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $767 → $768 | Hold | Maintains | $767 → $768 | +1.59% | Dec 12, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $700 → $745 | Hold | Maintains | $700 → $745 | -1.45% | Dec 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $850 → $1,057 | Strong Buy | Maintains | $850 → $1,057 | +39.82% | Dec 4, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $725 → $850 | Buy | Maintains | $725 → $850 | +12.44% | Dec 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $767 | Buy → Hold | Downgrades | $767 | +1.46% | Dec 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.